Sundaram Finance enters Q1 FY27 riding a wave of strong commercial vehicle demand, with industry sales posting their highest-ever Q1 volumes. Investors will be looking for confirmation that this sector momentum is translating into sustained AUM growth and stable asset quality as the company navigates a flat interest rate environment.
| Results date | August 03, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 2,066 Cr |
| Previous quarter PAT | Rs. 608 Cr |
| Market cap | Rs. 49,749.27 Cr |
| CMP | Rs. 4,475.75 |
The board meeting is scheduled for August 03, 2026, to consider the audited financial results.
Sundaram Finance is well-positioned to maintain its AUM growth in the 15-17% range, supported by a robust 18.3% YoY increase in industry commercial vehicle sales during Q1. While the company's asset quality showed a strong recovery in H2 FY26 with Gross Stage 3 at 1.44%, management will likely address whether the construction equipment segment's 3% industry-wide sales improvement is mitigating previous stress. Net interest income growth is expected to track AUM expansion closely, though the flat repo rate of 5.25% may lead to a mild sequential compression in margins compared to the 21% NII growth seen in FY26. The upcoming call will focus on the deployment of the approved Rs. 500 Cr Tier II NCD issuance and the impact of the new TReDS mandate on MSME collection efficiency.
AUM and Disbursement Momentum: Monitoring whether the 15-17% AUM growth pace sustained throughout FY26 continues into the new fiscal year.
Asset Quality and Segment Stress: Tracking the sustainability of the H2 FY26 recovery in Stage 3 metrics.
Capital and Liquidity Management: Managing capital adequacy and borrowing costs in a stable-rate environment.
Strategic Operational Updates: Updates on internal efficiency and portfolio consolidation.
The company maintained AUM growth in the 15-17% range throughout FY26, ending the year with AUM of Rs. 59,908 Cr. This represents a 16.4% growth rate, supported by strong disbursement momentum in the second half of the year.
Asset quality stabilized significantly in H2 FY26, with Gross Stage 3 ending at 1.44% and Net Stage 3 improving to 0.69%. This recovery followed elevated stress in H1 FY26, with provision coverage strengthening to 53%.
The standalone Capital Adequacy Ratio stood at 19.1% as of March 2026, remaining comfortably above the regulatory minimum of 15%. The board has approved raising up to Rs. 500 Cr via Tier II NCDs to further support this capital position.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now